Concert Pharmaceuticals Inc
NASDAQ:CNCE 3:59:52 PM EDT
Earnings Announcements
Concert Pharmaceuticals Reports First Quarter 2022 Financial Results
Published: 05/05/2022 11:19 GMT
Concert Pharmaceuticals Inc (CNCE) - Concert Pharmaceuticals Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $1.03.
Concert Pharmaceuticals - Expects Its Current Cash, Cash Equivalents and Investments to Fund Company Into Q4 of 2022.
Qtrly Loss per Share $1.03.
Q1 Earnings per Share View $-0.91 -- Refinitiv Ibes Data (analyst estimates).
Q1 Loss per Share $1.03.
Concert Pharmaceuticals - Expects Its Current Cash, Cash Equivalents and Investments to Fund Company Into Q4 of 2022.
Qtrly Loss per Share $1.03.
Q1 Earnings per Share View $-0.91 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.89
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.83
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.89
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.83
More details on our Analysts Page.